Prognostic Significance of Mucinous Differentiation of Endometrioid Adenocarcinoma of the Endometrium

REFERENCES

• American Cancer Society. Cancer Facts & Figures 2012. Atlanta: American Cancer Society, 2012.
   Google Scholar
• Musa F, Huang M, Adams B, Pirog E, Holcomb K. Mucinous histology is a risk factor for nodal metastases in endometrial cancer. Gynecol Oncol 2012;125:541–545.
   PubMed Web of Science ®Google Scholar
• Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR. Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 1983;7:715–729.
   PubMed Web of Science ®Google Scholar
• Tiltman AJ. Mucinous carcinoma of the endometrium. Obstet Gynecol 1980;55:244–247.
   PubMed Web of Science ®Google Scholar
• Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999;8:1117–1121.
   PubMed Web of Science ®Google Scholar
• Wright JD, Buck AM, Shah M, Burke WM, Schiff PB, Herzog TJ. Safety of ovarian preservation in premenopausal women with endometrial cancer. J Clin Oncol 2009;27:1214–1219.
   PubMed Web of Science ®Google Scholar
• Wright JD, Shah M, Mathew L, Bruke WM, Culhane J, Goldman N, Schiff PB, Herzog TJ. Fertility preservation in young women with epithelial ovarian cancer. Cancer 2009;115:4118–4126.
   PubMed Web of Science ®Google Scholar
• Wright JD, NathavithArana R, Lewin SN, Sun X, Deutsch I, Bruke WM, Herzog TJ. Fertility-conserving surgery for young women with stage IA1 cervical cancer: safety and access. Obstet Gynecol 2010;115:585–590.
   PubMed Web of Science ®Google Scholar
• Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA 2002;287:2106–2113.
   PubMed Web of Science ®Google Scholar
• Howard J, Hankey BF, Greenberg RS, Austin DF, Correa P, Chen VW, Durako S. A collaborative study of differences in the survival rates of black patients and white patients with cancer. Cancer 1992;69:2349–2360.
   PubMed Web of Science ®Google Scholar
• Hill HA, Eley JW, Harlan LC, Greenberg RS, Barrett RJ, II, Chen VW. Racial differences in endometrial cancer survival: the black/white cancer survival study. Obstet Gynecol 1996;88:919–926.
   PubMed Web of Science ®Google Scholar
• Hicks ML, Phillips JL, Parham G, Andrews N, Jones WB, Shingleton HM, Menck HR. The National Cancer Data Base Report on endometrial carcinoma in African-American women. Cancer 1998;83:2629–2637.
   PubMed Web of Science ®Google Scholar
• Wright JD, Fiorelli J, Schiff PB, Burke WM, Kansler AL, Cohen CJ, Herzog TJ. Racial disparities for uterine corpus tumors: changes in clinical characteristics and treatment over time. Cancer 2009;115:1276–1285.
   PubMed Web of Science ®Google Scholar
• Yoo SH, Park BH, Choi J, Yoo J, Lee SW, Kim YM, Kim KR. Papillary mucinous metaplasia of the endometrium as a possible precursor of endometrial mucinous adenocarcinoma. Mod Pathol 2012;25:1496–1507.
   PubMed Web of Science ®Google Scholar
• Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ 2nd, Alberts D, Curtin J. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:812–819.
   PubMed Web of Science ®Google Scholar
• Ambros RA, Sherman ME, Zahn CM, Bitterman P, Kurman RJ. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. Hum Pathol 1995;26:1260–1267.
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56:403–412.
   PubMed Web of Science ®Google Scholar
• Kuhn E, Wu RC, Guan B, Wu G, Zhang J, Wang Y, Song L, Yuan X, Wei L, Roden RB, Kuo KT, Nakayama K, Clarke B, Shaw P, Olvera N, Kurman RJ, Levine DA, Wang TL, Shih IeM. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst 2012;104:1503–1513.
   PubMed Web of Science ®Google Scholar
• Hayes MP, Wang H, Espinal-Witter R, Douglas W, Solomon GJ, Baker SJ, Ellenson LH. PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia. Clin Cancer Res 2006;12:5932–5935.
   PubMed Web of Science ®Google Scholar
• Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J. K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 1997;79:1581–1586.
   PubMed Web of Science ®Google Scholar
• Byron SA, Gartside M, Powell MA, Wellens CL, Gao F, Mutch DG, Goodfellow PJ, Pollock PM. FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features. PLoS One 2012;7:e30801.
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Longacre TA. Low-grade mucinous adenocarcinoma of the uterine corpus: a rare and deceptively bland form of endometrial carcinoma. Am J Surg Pathol 2011;35:537– 544.
   PubMed Web of Science ®Google Scholar
• Schiavone MB, Herzog TJ, Lewin SN, Deutsch I, Sun X, Burke WM, Wright JD. Natural history and outcome of mucinous carcinoma of the ovary. Am J Obstet Gynecol 2011;205: 480 e1–e8.
   PubMedGoogle Scholar
• Fleming GF, Brunetto VL, Cella D, Look KY, Reid GC, Munkarah AR, Kline R, Burger RA, Goodman A, Burks RT. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2004;22:2159–2166.
   PubMed Web of Science ®Google Scholar